Date: 21-Aug-2019

Lilly announces sale of legacy antibiotics brands and manufacturing facility in China

Lilly and Company has announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, Ceclor« and Vancocin«, as well as a manufacturing facility in Suzhou, China that produces Ceclor, to Eddingpharm, a China-based specialty pharmaceutical company.